DrugPatentWatch Database Preview

Details for Patent: 9,694,078

« Back to Dashboard

Which drugs does patent 9,694,078 protect, and when does it expire?

Patent 9,694,078 protects TYGACIL and is included in one NDA.

This patent has thirty-one patent family members in twenty-five countries.

Summary for Patent: 9,694,078

Title:	Tigecycline compositions and methods of preparation
Abstract:	The present invention relates to novel tigecycline compositions with improved stability in both solid and solution states and processes for making these compositions. These compositions comprise tigecycline, a suitable carbohydrate, and an acid or buffer.
Inventor(s):	Fawzi; Mahdi B. (Morristown, NJ), Zhu; Tianmin (Monroe, NY), Shah; Syed M. (Delray Beach, FL)
Assignee:	Wyeth LLC (New York, NY)
Application Number:	15/010,116
Patent Claim Types: see list of patent claims	Composition; Formulation; Process;

Drugs Protected by US Patent 9,694,078

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Pf Prism Cv	TYGACIL	tigecycline	POWDER;INTRAVENOUS	021821-001	Jun 15, 2005	AP	RX	Yes	Yes			Y

International Family Members for US Patent 9,694,078

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	053827
Argentina	109500
Australia	2006223226
Brazil	PI0608464